首页> 外文期刊>Journal of the advanced practitioner in oncology >Breast Cancer: ASCO2O Virtual Scientific Program Highlights for the Advanced Practitioner
【24h】

Breast Cancer: ASCO2O Virtual Scientific Program Highlights for the Advanced Practitioner

机译:乳腺癌:ASCO2O虚拟科学计划为先进的科学家突出显示

获取原文
获取原文并翻译 | 示例
           

摘要

Results of the phase III E2108 study indicate that surgery and radiotherapy given after systemic treatment afforded no additional survival benefit among women with newly diagnosed metastatic breast cancer. The practice may, however, reduce locoregional progression of disease, according to a report presented in the Plenary Session of the ASCO20 Virtual Scientific Program. "Based on the results of our study, women who present with a new diagnosis of breast cancer already in stage IV should not be offered surgery and radiation for the primary breast tumor with the expectation of a survival benefit," said lead investigator Seema A. Khan, MD, Professor of Surgery and the Bluhm Family Professor of Cancer Research at Northwestern University, Chicago. "When making these decisions, it is important to focus energy and resources on proven therapies that can prolong life."
机译:第三阶段E2108研究的结果表明,在新诊断的转移性乳腺癌患者中,全身治疗后进行的手术和放疗没有额外的生存益处。然而,根据ASCO20虚拟科学项目全体会议上提交的一份报告,这种做法可能会减少疾病的局部区域进展。首席研究员、芝加哥西北大学外科学教授和布鲁姆家族癌症研究教授Seema a.Khan医学博士说:“根据我们的研究结果,对于已经处于第四阶段的乳腺癌新诊断的女性,不应为原发性乳腺肿瘤提供手术和放疗,以期获得生存益处。”。“在做出这些决定时,重要的是将精力和资源集中在经验证的可以延长寿命的疗法上。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号